Protagenic Therapeutics I... (PTIX)
NASDAQ: PTIX
· Real-Time Price · USD
2.92
-0.15 (-4.89%)
At close: Aug 15, 2025, 3:59 PM
2.88
-1.41%
After-hours: Aug 15, 2025, 07:55 PM EDT
Protagenic Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -1.44M | -1.55M | -640.78K | -1.61M | -1.72M | -1.68M | -1.4M | -1.21M | -718.1K | -601.37K | -925.3K | -666.72K | -1.36M | -890.39K | -878.3K | -1.55M | -1.21M |
Depreciation & Amortization | 12.57K | 12.57K | 12.57K | 12.57K | 12.57K | 26.62K | 1.42K | 91.00 | 90.00 | 30.00 | n/a | n/a | 26.63K | 427.14K | n/a | n/a | 53.98K |
Stock-Based Compensation | 236.01K | 245.44K | 250.4K | 265.44K | 161.86K | 166.71K | 166.71K | 166.71K | 166.71K | 198.69K | 214.68K | 215.53K | 235.78K | 218.17K | 231.65K | 722.97K | 345.98K |
Other Working Capital | n/a | 556.35K | 280.96K | -171.83K | -109.13K | -42.04K | 545.11K | -633.07K | 150.13K | 281.8K | 138.15K | -133.31K | 675.75K | -124.32K | -529.46K | -109.2K | 203.69K |
Other Non-Cash Items | n/a | -80.41K | -88.81K | -51.53K | 186.81K | 734.94K | 4.45K | 25.18K | 29.33K | 31.52K | 37.24K | 33.26K | 31.58K | 48.84K | 100.67K | 223.64K | 53.98K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | -219.94K | 23.18K | 118.95K | n/a | n/a | n/a | n/a | -26.63K | -424.65K | n/a | n/a | -137.65K |
Change in Working Capital | 123.4K | 556.35K | 192.15K | -171.83K | -109.13K | -176.57K | 545.11K | -633.07K | 150.13K | 190.2K | 138.15K | -452.4K | 664.18K | 215.8K | -529.46K | -109.2K | 282.46K |
Operating Cash Flow | -1.07M | -819.79K | -185.66K | -1.55M | -1.66M | -1.14M | -655.77K | -1.53M | -371.83K | -180.94K | -535.23K | -847.08K | -430.56K | -405.09K | -1.08M | -710.38K | -607.71K |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | -93.97K | -55.81K | n/a | n/a | -1.8K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | -2.37K | 68.78K | n/a | n/a | -57.31K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | -297.12K | -2.75M | -12.98K | n/a | n/a | 69.24K | -103.36K | n/a | n/a | -10.4M | -10.4M | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | -51.73K | 1.6M | 1.5M | 5.12M | 659.51K | 1.61M | 294.67K | 94.33K | 460.89K | 706.92K | 370.76K | 488.43K | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | 198.00 | 2.37K | -68.78K | 1.61K | n/a | 57.31K | 357.53 | 706.92K | 370.76 | 10.39M | -10.4K | n/a | n/a |
Investing Cash Flow | n/a | n/a | n/a | 1.6M | 1.2M | 2.28M | 590.72K | 1.61M | 294.67K | 161.77K | 357.53K | 706.92K | 370.76K | 485.95K | -10.4M | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 100K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 12.45M | 27.13K |
Financial Cash Flow | 102.52K | 1.6M | 316.96K | 44.53K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 12.45M | 127.13K |
Net Cash Flow | -965.51K | 782.66K | 131.21K | 92.82K | -456.12K | 1.13M | -66.11K | 80.94K | -76.7K | 56.87K | -180.34K | -143.51K | -59K | 81.06K | -11.47M | 11.74M | -479.42K |
Free Cash Flow | -1.07M | -819.79K | -185.66K | -1.55M | -1.66M | -1.24M | -711.57K | -1.53M | -371.83K | -182.74K | -535.23K | -847.08K | -430.56K | -405.09K | -1.08M | -710.38K | -607.71K |